Gregory A McClelland

Title: Gregory A McClelland: Innovator in Pharmaceutical Formulations

Introduction

Gregory A McClelland is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical formulations, particularly in treatments for women's health issues. With a total of 4 patents, his work focuses on innovative solutions for conditions such as endometriosis and polycystic ovary syndrome.

Latest Patents

McClelland's latest patents include pharmaceutical formulations designed for treating endometriosis, uterine fibroids, polycystic ovary syndrome, and adenomyosis. These patents detail pharmaceutical compositions that comprise a gonadotropin-releasing hormone (GnRH) antagonist. The disclosures also cover methods of preparing and using these compositions, as well as techniques for facilitating the release of a GnRH antagonist from a pharmaceutical formulation.

Career Highlights

Throughout his career, McClelland has worked with prominent companies in the pharmaceutical industry, including Neurocrine Biosciences, Inc. and AbbVie Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation.

Collaborations

Some of McClelland's notable coworkers include Richard Alexander Moore, Jr. and Anna V Stepanenko. Their collaborative efforts have contributed to advancements in the pharmaceutical field.

Conclusion

Gregory A McClelland's work in pharmaceutical formulations showcases his dedication to improving women's health through innovative treatments. His patents reflect a commitment to addressing significant medical challenges, making him a valuable contributor to the field.